A5001525235- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Natural product bioactivities and synthesis
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Radiomics and Machine Learning in Medical Imaging
- Air Quality and Health Impacts
- MicroRNA in disease regulation
- Traditional Chinese Medicine Analysis
- Glioma Diagnosis and Treatment
- Nutrition and Health in Aging
- Cancer Mechanisms and Therapy
- Colorectal Cancer Screening and Detection
Kunming Medical University
2023-2025
Tobacco is a significant risk factor for bladder cancer, with notable disparities in smoking rates and cancer prevalence between sex. Our objective to assess the sex- age-specific burden of attributable China from 1990 2021, predict its future trends over next 15 years using GBD study data. All data were extracted 2021 study, utilizing metrics such as mortality rates, disability-adjusted life (DALYs), age-standardized (ASMR), DALY (ASDR) describe smoking-attributable China. We employed...
Bladder cancer (BC) is the tenth most commonly diagnosed cancer. High recurrence, chemoresistance, and low response rate hinder effective treatment of BC. Hence, a novel therapeutic strategy in clinical management BC urgently needed. Medicarpin (MED), an isoflavone from Dalbergia odorifera, can promote bone mass gain kill tumor cells, but its anti-BC effect remains obscure. This study reve aled that MED effectively inhibited proliferation arrested cell cycle at G1 phase lines T24 EJ-1 vitro....
Abstract Background Isolinderalactone (ILL), extracted from the dried tubers of Linderae aggregate, has multiple functions, such as antioxidation, antitumor, and anti-infection effects. However, there have been few studies on ILL's antitumor role no reports its in bladder cancer (BC). Materials methods Human BC cell lines T24 EJ-1 were treated with different concentrations ILL (0, 10, 20, 50, 100, 200, 400, 600, 800, 1000 μmol/L), proliferation inhibition rate was analyzed using CCK-8 assay....